Melinta Therapeutics Presenting In Vivo and In Vitro Results from Baxdela Studies at ASM Microbe

World News: . []

New Haven Conn June 01 2017 GLOBE NEWSWIRE -- Melinta Therapeutics a privately held company developing novel antibiotics to treat serious bacterial infections announced today that five presentations of clinical in vitro and pharmacokinetic result...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 19:42 GMT Thursday 1st June 2017

Published: .

Search for other references to "melinta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us